Controlled Fluid Resuscitation Strategy in Sepsis Patient
| Registry | NCT03214913 |
|---|---|
| Status | Unknown |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: single, treatment |
| Enrollment | 550 (Estimated) |
| Sponsor | Ruijin Hospital (Other); collaborators: RenJi Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
| Conditions | Sepsis |
| Interventions | Early Goal Directed Therapy, Ruijin Strategy (Other) |
| Dates | start 2018-01-01 (estimated), primary completion 2020-12-31 (estimated), completion 2021-06-30 (estimated), first posted 2017-07-12, last updated 2017-07-12 |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Sepsis All trials of Early Goal Directed Therapy All trials of Ruijin Strategy
To evaluate two different strategy of fluid resuscitation in sepsis patients
Early goal-directed fluid therapy (EGDT) had been regarded as an important fluid therapy strategy in early sepsis or septic shock patients. In recent years, several randomized control studies showed the EGDT therapy cannot make a better outcome in sepsis patients compared to the standard therapy. A strategy of controlled fluid resuscitation had showed good outcome in critical illness such as severe acute pancreatitis, major trauma. But many aspects of the so-called controlled fluid resuscitation remained controversial. In a previous study on severe acute pancreatitis, we described a bundle of controlled fluid resuscitation which had showed an ideal result with higher survival rate. So, we are going to use the bundle on sepsis patients, and to see if it can bring a better out come in sepsis patients compared to the EGDT strategy. This study aims to determine a better strategy of fluid resuscitation in sepsis patients
| Arm | Type | Interventions | Description |
|---|---|---|---|
| EGDT Group | Other | Other: Early Goal Directed Therapy | Early Goal Directed Therapy ：30ml/kg in the first bolus to have a CVP（central venous pressure） 8-12 mmHg and MAP（mean artery pressure ） 65-85 mm Hg,and urine output ≥0.5 ml/kg/h, ScvO2 ≤70%；If not, use noradrenaline，red blood cell transfusion if necessary. |
| Ruijin Group | Other | Other: Ruijin Strategy | Ruijin Strategy therapy：10\~5ml/kg/h，crystalloid vs colloid 2:1 resuscitation;using noradrenaline at the same time;red blood cell transfusion if necessary. target： fulfillment of two or more of four criteria:1. HR（heart rate） <120 beats/min, 2.MAP 65-85 mm Hg, 3. urine output ≥1 ml/kg /h 4. HCT（hematocrit） 25%\~35%. |
Sex: All, ages: 8 Years to 80 Years
Inclusion Criteria: * 1.sepsis patients in accordance with the Sepsis 3.0 definition(SOFA increase ≥2 compared to the baseline，due to infection ) * 2.the first blood lactate in our hospital is ≥ 4mmol/L or MAP<90mmHg after 20ml/kg fluid bolus * 3.the shock is diagnosed within 24hrs after onset Exclusion Criteria: * \- 1.<18 years old * 2.Pregnancy * 3 with co-morbidity such as AE-COPD, stroke, seizure, lung edema, acute coronary syndrome * 4 with contra-indication of CVC(central venous catheter) placement * 5 trauma or major burn * 6 poisoning * 7 any cancer receiving chemotherapy * 8.immunosuppression (for organ transplantation or disease of immune system) * 9.acute pancreatitis * 10.relapse sepsis